Press Releases

Lexington, Mass., June 3, 2009 – GI Dynamics, a leader in non-surgical, endoscopic approaches for the treatment of type 2 diabetes and obesity, today announced that its EndoBarrier Gastrointestinal Liner will be highlighted by leading experts in metabolic disorders and endoscopy at several...

Study Findings Show the EndoBarrier Liner Combined with the EndoBarrier Flow Restrictor Enhances Weight Loss Effect in a Porcine Model  Lexington, Mass., April 25, 2009 – GI Dynamics, a leader in non-surgical, endoscopic approaches for treating type 2 diabetes and obesity, today announced the...

EndoBarrier Technology Subject of Presentations at Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2009 Annual Meeting and the European Congress on Obesity (ECO) 2009 Meeting  Lexington, Mass., April 20, 2009 – GI Dynamics, a company pioneering devices to improve glycemic...

Lexington, Mass., February 19, 2009 – GI Dynamics today announced that it has closed an additional $15 million in Series C financing. With this additional funding, GI Dynamics has closed a total of $45 million in Series C financing, bringing the total raised by GI Dynamics since its inception to...

Lexington, MA, January 7, 2009 – GI Dynamics, a medical device company pioneering the development of new approaches to treat obesity and metabolic disorders, today announced that it has received ISO 13485:2003 certification for the company’s Lexington facility. The company has also received...

Data Support Weight Loss and Glucose Results Observed in Clinical Trials of EndoBarrier™; Study Recognized by Obesity Society at 2008 Annual Meeting  LEXINGTON, Mass., November 18, 2008 – GI Dynamics, a medical device company pioneering the development of new approaches to treat obesity and type 2...

New Clinical Data Presented at IFSO Show Excellent Short Term Weight Loss Results in Morbidly Obese Patients Buenos Aires, Argentina, September 26, 2008 – GI Dynamics, a medical device company pioneering the development of new approaches to treat obesity and metabolic disorders, today announced...

(IFSO) 13th World Congress LEXINGTON, Mass., September 19, 2008 – GI Dynamics, a medical device company pioneering the development of new approaches to treating metabolic disorders, today announced that new data regarding EndoBarrier™, its novel, noninvasive device currently in clinical trials to...

Compelling Clinical Data Highlighted at First World Congress on Interventional Therapies for Type 2 Diabetes Show Improved Glycemic Control and Weight Reduction in Uncontrolled Diabetics NEW YORK, NY, September 16, 2008 – GI Dynamics, a medical device company pioneering the development of new...

LEXINGTON, Mass., September 9, 2008 – GI Dynamics, a medical device company pioneering the development of new approaches to treating metabolic disorders, today announced that new data regarding EndoBarrier™, its novel, noninvasive device currently in clinical trials to treat obesity and type 2...